Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHinge Health Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 7 | $0.34 | $0.44 | $0.40 |
| Q2 2026 | 9 | $0.51 | $0.70 | $0.62 |
| Q3 2026 | 9 | $0.52 | $0.71 | $0.61 |
| Q4 2026 | 9 | $0.58 | $0.81 | $0.69 |
| Q1 2027 | 6 | $0.63 | $0.67 | $0.64 |
| Q2 2027 | 3 | $0.74 | $0.79 | $0.76 |
| Q3 2027 | 3 | $0.78 | $0.83 | $0.80 |
| Q4 2027 | 6 | $0.88 | $0.93 | $0.90 |
| Q1 2028 | 8 | $0.88 | $0.94 | $0.91 |
| Q2 2028 | 4 | $0.96 | $1.02 | $0.98 |
| Q3 2028 | 5 | $1.00 | $1.06 | $1.03 |
| Q4 2028 | 8 | $1.04 | $1.11 | $1.07 |
Hinge Health Inc. Earnings Date And Information
Hinge Health Inc. last posted its earnings results on Tuesday, August 4th, 2026. The company reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.615 by $0.025. The company had revenue of 212.82 M for the quarter and had revenue of 587.86 M for the year. Hinge Health Inc. has generated $-5 earnings per share over the last year ($-5.19 diluted earnings per share) and currently has a price-to-earnings ratio of 65.66. Hinge Health Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Hinge Health Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2026 | Q2 2026 | N/A | $0.55 | N/A | $201.46 M | $212.82 M |
| 05/07/2026 | Q1 2026 | N/A | $0.43 | N/A | $172.20 M | $182.31 M |
| 03/03/2026 | Q4 2025 | N/A | $0.39 | N/A | $156.66 M | $170.73 M |
| 11/07/2025 | Q3 2025 | N/A | -$0.02 | N/A | $142.14 M | $154.21 M |
| 08/11/2025 | Q2 2025 | N/A | -$7.38 | N/A | $125.38 M | $139.10 M |
| 03/31/2025 | Q1 2025 | N/A | $1.55 | N/A | N/A | $123.83 M |
| 12/30/2024 | Q4 2024 | N/A | $0.35 | N/A | N/A | $117.26 M |
| 09/29/2024 | Q3 2024 | N/A | $0.00 | N/A | N/A | $100.62 M |
| 06/29/2024 | Q2 2024 | N/A | -$0.19 | N/A | N/A | $89.83 M |
| 03/31/2024 | Q1 2024 | N/A | -$0.34 | N/A | N/A | $82.71 M |
| 12/30/2023 | Q4 2023 | N/A | -$0.31 | N/A | N/A | $81.52 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.21 | N/A | N/A | $81.35 M |
| 06/29/2023 | Q2 2023 | N/A | -$0.41 | N/A | N/A | $69.84 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Hinge Health Inc. Earnings: FAQ's
The conference call for Hinge Health Inc.'s latest earnings report can be listened to online.
The conference call transcript for Hinge Health Inc.'s latest earnings report can be read online.
Hinge Health Inc. (:HNGE) has a recorded annual revenue of $587.86 M.
Hinge Health Inc. (:HNGE) has a recorded net income of $-528,260,999.Hinge Health Inc. has generated $-5.36 earnings per share over the last four quarters.
Hinge Health Inc. (:HNGE) has a price-to-earnings ratio of 65.66 and price/earnings-to-growth ratio is 0.86.